ArticleBiomarker research2024

Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer.

Federica Ganci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.